Results 51 to 60 of about 469,662 (394)

Comorbid mood and anxiety disorders, suicidal behavior, and substance abuse among Black Caribbeans in the U.S.A. [PDF]

open access: yes, 2012
The purpose of this study was to examine nativity and country of origin differences in comorbid mood (major depressive disorder, dysthymia, and bipolar I and II disorders) and anxiety (post-traumatic stress disorder, panic disorder, agora- phobia, social
Chatters, Linda M.   +4 more
core   +1 more source

Genetics of generalized anxiety disorder and related traits

open access: yesDialogues in Clinical Neuroscience, 2017
This review serves as a systematic guide to the genetics of generalized anxiety disorder (GAD) and further focuses on anxiety-relevant endophenotypes, such as pathological worry fear of uncertainty, and neuroticism.
M. Gottschalk, K. Domschke
semanticscholar   +1 more source

Post-stroke depresion and anxiety [PDF]

open access: yesTrakia Journal of Sciences, 2019
The aim of the study was to investigate the clinical features of depression and the relationship between depression and generalized anxiety disorder. Material and methods: 93 patients with stroke were examined, of whom 59 men (39-83 years) and 34 women ...
D. Komsiyska, Y. Petkov
doaj   +1 more source

The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders a randomized clinical trial [PDF]

open access: yes, 2017
IMPORTANCE: Transdiagnostic interventions have been developed to address barriers to the dissemination of evidence-based psychological treatments, but only a few preliminary studies have compared these approaches with existing evidence-based ...
Ametaj, Amantia   +13 more
core   +1 more source

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

BCS1L‐Associated Disease: 5′‐UTR Variant Shifts the Phenotype Towards Axonal Neuropathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the consequences of a pathogenic missense variant (c.838C>T; p.L280F) and a 5′‐UTR regulatory variant (c.‐122G>T) in BCS1L on disease pathogenesis and to understand how regulatory variants influence disease severity and clinical presentation.
Rotem Orbach   +11 more
wiley   +1 more source

Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical ...
Andrea Nova   +5 more
wiley   +1 more source

Cumulative lifetime violence severity, social determinants and anxiety in a national sample of Canadian men

open access: yesBMC Psychiatry, 2022
Background Despite anxiety disorders being the ninth leading cause of disability and associated with social inequities, little attention has been given to how intersections among social determinants of health and chronic stressors such as cumulative ...
Kelly Scott-Storey   +7 more
doaj   +1 more source

A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators [PDF]

open access: yes, 2017
INTRODUCTION: Social anxiety disorder (SAD) is among the most prevalent mental disorders, associated with impaired functioning and poor quality of life. Pharmacotherapy is the most widely utilized treatment option.
Borenstein M   +8 more
core   +2 more sources

The burden of generalized anxiety disorder in Canada.

open access: yesHealth Promotion and Chronic Disease Prevention in Canada, 2017
INTRODUCTION Although generalized anxiety disorder (GAD) is common and disabling, there are few Canadian studies on this mental illness. We compared the characteristics, health status, health services use and health care needs of Canadians with GAD to ...
L. Pelletier   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy